Qorium, a biotech company developing cultured leather, has successfully raised €22 million in Series A funding to scale production and penetrate the luxury market.
Target Information
Qorium, a Maastricht-based biotech company, is pioneering the production of cultured leather, having successfully completed a Series A funding round of €22 million. The investment was secured from a variety of sources, including Invest-NL, LIOF, Brightlands Venture Partners, Sofinnova Partners, and a collective of private investors.
Qorium specializes in developing authentic leather from a few animal cells, eliminating the need for traditional livestock farming and significantly reducing environmental impact. Their innovative technology provides a sustainable alternative to conventional leather, known for its high CO₂ emissions, excessive water usage, and chemical waste.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in the Netherlands
The cultured leather industry is emerging as a crucial sector in the Netherlands, driven by increasing consumer demand for sustainable and ethical products. The country has established a strong foundation in biotechnology, suppo
Similar Deals
Social Impact Ventures, SHIFT Invest, Quadia → The Renewal Workshop
2023
Amsterdam Klimaat en Energie Fonds (AKEF) → New Optimist
2023
Invest-NL
invested in
Qorium
in 2025
in a Series A deal
Disclosed details
Transaction Size: $23M